Jun 02, 2026

Sanofi (SASY) Deploys AI Sales Assistant Powered by Snowflake Technology

Sanofi (SASY) introduces AI sales agent on Snowflake platform, transforming pre-call prep from hours to seconds as SNOW drops 8.48...

Jun 02, 2026

Nu Holdings (NU) Stock Plunges to 52-Week Low Following Executive Shakeup

Nu Holdings (NU) stock crashed to a 52-week low after CFO change, Q1 earnings shortfall, and BofA downgrade. Shares down 26% in si...

Jun 02, 2026

Super Micro Computer (SMCI) Stock Surges 5%+ Following Computex AI Platform Laun...

SMCI stock jumped 5%+ after launching AMD Helios and Arm AGI CPU platforms at Computex 2026. Mizuho raised price target despite su...

Jun 02, 2026

HP (HPQ) Stock Surges to 52-Week Peak Following NVIDIA RTX Spark PC Debut

HP (HPQ) stock climbed 8.9% to a 52-week high of $29.55 after unveiling NVIDIA RTX Spark PCs and reporting Q2 EPS of $0.86, surpas...

Jun 02, 2026

Mastercard (MA) Stock Plunges to 52-Week Low Amid Executive Reshuffle

Mastercard (MA) stock fell to a 52-week low of $480.27 amid executive changes and FCA investigation, despite reporting strong Q1 r...

Jun 02, 2026

Seagate (STX) Stock Surges to Record High on AI Boom and Legal Settlement

Seagate (STX) stock soared to $941, driven by NVIDIA's RTX Spark chip, a $175M settlement, and analyst price targets reaching $1,1...

Jun 02, 2026

Victoria’s Secret (VSXY) Shares Skyrocket 40% Following Stellar Q1 Results

Victoria's Secret (VSXY) shares jumped 40% after Q1 earnings doubled estimates at $0.60. Revenue increased 15% and the company upg...

Jun 02, 2026

Arm Holdings (ARM) Stock Soars 14% Following Nvidia’s Arm-Powered Chip Reveal at...

Arm (ARM) stock jumped 14% after Nvidia announced two Arm-based chips at Computex, expanding royalty revenue streams across PCs an...

Jun 02, 2026

Microchip Technology (MCHP) Soars 14% on Data Center Growth Forecast

Microchip Technology (MCHP) stock rallied 14.5% after revealing its data center unit revenue hit $302.7M in 2025 with 65% growth e...

Jun 02, 2026

Abivax (ABVX) Stock Plunges 32% Despite Breakthrough Trial Results

Abivax (ABVX) stock crashed 32% despite best-in-class Phase 3 results as rare cancer cases in trial participants triggered safety...